Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2017-10-10 2017-08-01
Drug Identification Number 02245688 02245688
Brand name RATIO-TOPISALIC RATIO-TOPISALIC
Common or Proper name TOPISALIC TOPISALIC
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BETAMETHASONE SALICYLIC ACID BETAMETHASONE SALICYLIC ACID
Strength(s) 0.5MG 20MG 0.5MG 20MG
Dosage form(s) LOTION LOTION
Route of administration TOPICAL TOPICAL
Packaging size 60ML 60ML
ATC code D07XC D07XC
ATC description CORTICOSTEROIDS, OTHER COMBINATIONS CORTICOSTEROIDS, OTHER COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-07-30 2017-07-30
Estimated end date 2017-10-10 2017-10-10
Actual end date 2017-10-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments